Trinity Biotech (TRIB) Profit After Tax (2009 - 2024)

Trinity Biotech (TRIB) has reported Profit After Tax for 16 consecutive years, with -$16.4 million the latest figure, recorded in Q4 2024.

• Quarterly Profit After Tax fell 197.75% year-over-year to -$16.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$31.2 million (up 15.34% YoY) and the FY2025 annual result came in at -$2.3 million, down 63.7% from the prior year.
• Profit After Tax retreated to -$16.4 million in Q4 2024 per TRIB's latest filing, from -$4.8 million in the prior quarter.
• Over the last five years, Profit After Tax for TRIB reached as high as $7.3 million in Q3 2020 and fell as low as -$18.3 million in Q2 2023.
• A 5-year average of -$5.3 million and a median of -$5.1 million in 2023 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2020 — Profit After Tax jumped 732499999900.0% — and 2022, when it plunged 16974026074.03%.
• Year by year, Profit After Tax stood at -$0.48 in 2020, then sank by 263333233.33% to -$1.3 million in 2021, then tumbled by 724.05% to -$10.4 million in 2022, then surged by 47.18% to -$5.5 million in 2023, then slumped by 197.75% to -$16.4 million in 2024.
• According to Business Quant data, Profit After Tax over the past three periods registered -$16.4 million, -$4.8 million, and -$6.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.